These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2467224)

  • 81. Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action.
    Picazo O; López-Rubalcava C; Fernández-Guasti A
    Brain Res Bull; 1995; 37(2):169-75. PubMed ID: 7606493
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus.
    Laaris N; Haj-Dahmane S; Hamon M; Lanfumey L
    Neuropharmacology; 1995 Sep; 34(9):1201-10. PubMed ID: 8532191
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of 5-HT1A receptor agonists on the circadian rhythm of wheel-running activity in hamsters.
    Tominaga K; Shibata S; Ueki S; Watanabe S
    Eur J Pharmacol; 1992 Apr; 214(1):79-84. PubMed ID: 1316283
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Increase in the isolation-induced social behavioural deficit by agonists at 5-HT1A receptors.
    Francès H; Khidichian F; Monier C
    Neuropharmacology; 1990 Feb; 29(2):103-7. PubMed ID: 1970424
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.
    Garratt JC; Crespi F; Mason R; Marsden CA
    Eur J Pharmacol; 1991 Jan; 193(1):87-93. PubMed ID: 1710990
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levels.
    Matheson GK; Raess BU; Tunnicliff G
    Gen Pharmacol; 1996 Mar; 27(2):355-61. PubMed ID: 8919656
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Nader MA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release.
    Kidd EJ; Garratt JC; Marsden CA
    Eur J Pharmacol; 1991 Jul; 200(1):131-9. PubMed ID: 1837523
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.
    File SE; Gonzalez LE
    Pharmacol Biochem Behav; 1996 May; 54(1):123-8. PubMed ID: 8728549
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dependence of serotonin release in the locus coeruleus on dorsal raphe neuronal activity.
    Kaehler ST; Singewald N; Philippu A
    Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):386-93. PubMed ID: 10498288
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone.
    Carli M; Prontera C; Samanin R
    Br J Pharmacol; 1989 Apr; 96(4):829-36. PubMed ID: 2568143
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacological characteristics of 5-hydroxytryptamine autoreceptors in rat brain slices incorporating the dorsal raphe or the suprachiasmatic nucleus.
    O'Connor JJ; Kruk ZL
    Br J Pharmacol; 1992 Jul; 106(3):524-32. PubMed ID: 1504738
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
    Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Blockade of the anxiolytic-like action of ipsapirone and buspirone, but not that of 8-OH-DPAT, by adrenalectomy in male rats.
    López-Rubalcava C; Cruz SL; Fernández-Guasti A
    Psychoneuroendocrinology; 1999 May; 24(4):409-22. PubMed ID: 10341368
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus.
    Hogg S; Andrews N; File SE
    Neuropharmacology; 1994; 33(3-4):343-8. PubMed ID: 7984272
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dissociation of hippocampal serotonin release and locomotor activity following pharmacological manipulations of the median raphe nucleus.
    Shim I; Javaid J; Wirtshafter D
    Behav Brain Res; 1997 Dec; 89(1-2):191-8. PubMed ID: 9475626
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Behavioral deficits and exaggerated feedback control over raphe-hippocampal serotonin neurotransmission in restrained rats.
    Haleem DJ
    Pharmacol Rep; 2011; 63(4):888-97. PubMed ID: 22001976
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
    Yocca FD
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.